Skip to main content
Frontiers in Microbiology logoLink to Frontiers in Microbiology
. 2025 Dec 31;16:1741710. doi: 10.3389/fmicb.2025.1741710

Correction: Evaluation of the in vitro susceptibility of clinical isolates of NDM-producing Klebsiella pneumoniae to new antibiotics included in a treatment regimen for infections

Natalia Słabisz 1,*, Patrycja Leśnik 2, Jarosław Janc 3, Miłosz Fidut 4, Marzenna Bartoszewicz 5, Ruth Dudek-Wicher 5, Urszula Nawrot 5
PMCID: PMC12801513  PMID: 41541283

In the published version, the Funding statement reads:

“The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.”

This information is incomplete. The correct Funding statement should be:

“The author(s) declared that financial support was received for this work and/or its publication. Publication of this article was supported by Wroclaw Medical University statutory grant number SUBZ.D230.24.001.”

The original article has been updated.

Footnotes

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Microbiology are provided here courtesy of Frontiers Media SA

RESOURCES